Who has invested in LifeMine Therapeutics?

Fidelity Management & Research Company, Invus, 3W Partners Capital, GSK, GV, ARCH Venture Partners are named among the investors backing LifeMine Therapeutics.

LifeMine Therapeutics Funding: $300M Raised, Series C (2022)

LifeMine Therapeutics funding overview

LifeMine Therapeutics is based in Cambridge, Massachusetts. LifeMine Therapeutics has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in March 2022. The round record for LifeMine Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Fidelity Management & Research Company, Invus, 3W Partners Capital, GSK, GV, ARCH Venture Partners and 2 others. 8 distinct backers are named across the disclosed rounds.

LifeMine Therapeutics at a glance

Total raised: $300M
Latest round: Series C
Latest round date: March 2022
Headquarters: Cambridge, Massachusetts
Notable investors: Fidelity Management & Research Company, Invus, 3W Partners Capital, GSK, GV, ARCH Venture Partners, Blue Pool Capital, MRL Ventures Fund

Frequently asked about LifeMine Therapeutics funding

How much has LifeMine Therapeutics raised?: LifeMine Therapeutics has raised $300M in total disclosed funding across the rounds on record.
Who has invested in LifeMine Therapeutics?: Fidelity Management & Research Company, Invus, 3W Partners Capital, GSK, GV, ARCH Venture Partners are named among the investors backing LifeMine Therapeutics.
What was the latest LifeMine Therapeutics funding round?: The most recent disclosed round is a Series C, announced in March 2022.
Where is LifeMine Therapeutics based?: LifeMine Therapeutics is based in Cambridge, Massachusetts.
When did LifeMine Therapeutics last raise?: The last disclosed LifeMine Therapeutics round closed in March 2022 at Series C.

Every LifeMine Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.

LifeMine Therapeutics Funding: $300M Raised, Series C (2022)

LifeMine Therapeutics funding overview

LifeMine Therapeutics at a glance

Frequently asked about LifeMine Therapeutics funding

Companies related to LifeMine Therapeutics (35)

Browse related funding lists (8)